Saturday, December 20, 2014 Last update: 8:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Edwards Lifesciences

News articles for Edwards Lifesciences:

Monday, June 30, 2014

  • Edwards Receives FDA Clearance For Advanced Noninvasive Monitoring System
    IRVINE, Calif., June 30, 2014 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ClearSight system. To view the multimedia assets associated with this release, please click: ... read more

Thursday, May 29, 2014

  • Edwards Lifesciences to Present at Upcoming Investor Conferences
    IRVINE, CA -- (Marketwired) -- 05/29/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the following investor conferences in June. June 4 - Jefferies Global Healthcare Conference, New York - Scott B. Ullem, chief financial ... read more

Tuesday, May 20, 2014

Friday, May 2, 2014

  • Edwards Lifesciences to Webcast Annual Meeting of Stockholders
    IRVINE, CA -- (Marketwired) -- 05/02/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, will host its Annual Meeting of Stockholders on Thursday, May 8, 2014 beginning at 10:00 a.m. PT (1:00 pm ET) at its corporate headquarters in ... read more

Wednesday, April 30, 2014

Thursday, April 24, 2014

  • Edwards Lifesciences Reports Strong First Quarter Results
    IRVINE, CA -- (Marketwired) -- 04/24/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended March 31, 2014 of $60.3 million, or $0.56 per diluted share, and non-GAAP net income of $82.1 ... read more

Monday, April 21, 2014

  • Edwards Lifesciences Comments on U.S. Appeals Court Order
    IRVINE, CA -- (Marketwired) -- 04/21/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced that the U.S. Court of Appeals for the Federal Circuit today issued a stay for the preliminary injunction that was ordered on April 11 ... read more

Thursday, April 10, 2014

Friday, April 4, 2014

  • EDWARDS INTUITY Elite Valve System Receives CE Mark
    IRVINE, CA -- (Marketwired) -- 04/04/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark for the advanced EDWARDS INTUITY Elite valve system. This next-generation, rapid deployment system facilitates smaller incisions in ... read more

Thursday, March 6, 2014

Wednesday, February 5, 2014

Monday, February 3, 2014

  • Edwards Lifesciences Reports Strong Fourth Quarter Results
    IRVINE, CA -- (Marketwired) -- 02/03/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2013, of $75.8 million, or $0.68 per diluted share, and non-GAAP net income of $101.5 ... read more

Monday, January 27, 2014

  • Edwards Receives European Approval for Advanced SAPIEN 3 Valve
    IRVINE, CA -- (Marketwired) -- 01/27/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received CE Mark in Europe and is initiating the launch of its most advanced transcatheter aortic valve, the Edwards SAPIEN ... read more

Tuesday, January 21, 2014

Monday, January 13, 2014

  • Edwards to Begin U.S. Trial of SAPIEN 3 Valve for Intermediate Risk Patients
    IRVINE, CA -- (Marketwired) -- 01/13/14 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate a single-arm, non-randomized clinical trial ... read more

Thursday, January 9, 2014

Monday, December 9, 2013

Friday, December 6, 2013

Thursday, December 5, 2013

  • Edwards Lifesciences Announces Appointment of CFO
    IRVINE, CA -- (Marketwired) -- 12/05/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has chosen Scott B. Ullem as the company's next corporate vice president, chief financial officer (CFO). Ullem will succeed Thomas M. Abate, ... read more

Thursday, November 14, 2013

  • Edwards Comments on German Appellate Court Ruling
    IRVINE, CA -- (Marketwired) -- 11/14/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today said that an appeals court in Germany has suspended the enforcement of an injunction against sales of Medtronic's transcatheter heart valves in Germany, pending ... read more